Have MPN Disparities Been Addressed by Institutions?
https://vimeo.com/845098642 Have myeloproliferative neoplasm (MPN) disparities been addressed by institutions? Expert Dr. Idoroenyi Amanam from City of Hope explains MPN disparities that need to be improved, how institutions can collaborate on improvements,…
Are There Any MPN Disparities in Subtypes and Genetics?
https://vimeo.com/845094975 Are there any myeloproliferative neoplasm (MPN) disparities seen in subtypes and genetics? Expert Dr. Idoroenyi Amanam from City of Hope explains what studies have shown, the role of access to care,…
What Does the Future of Myeloproliferative Neoplasm Care Look Like?
https://vimeo.com/845089853 What does the future of myeloproliferative neoplasm (MPN) care look like for patients? Expert Dr. Idoroenyi Amanam from City of Hope explains how MPN treatments have changed in recent decades, symptoms…
Are MPN Risks and Outcomes Impacted by Race or Ethnicity?
https://vimeo.com/845093196 Are myeloproliferative neoplasm (MPN) risks and outcomes impacted by patient race or ethnicity? Expert Dr. Idoroenyi Amanam from City of Hope explains common MPN symptoms, potential risks and outcomes, and patient…
Myeloproliferative Neoplasm Basics for Newly Diagnosed Patients
https://vimeo.com/845099068 What do newly diagnosed myeloproliferative neoplasm (MPN) patients need to know? Expert Dr. Idoroenyi Amanam from City of Hope shares how he explains the condition, possible MPN complications, and proactive questions…
How Can You Access Personalized Medicine for Gastric Cancer?
https://vimeo.com/842695624 What is the right therapy for your gastric cancer? This animated video reviews treatment decision considerations, how results of essential testing may impact therapy, and advice for engaging in…
Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)
https://vimeo.com/841012721 AML expert Dr. Omer Jamy discusses his approach when considering treatment for patients with relapsed or refractory AML, including transplant eligibility, molecular markers, and whether clinical trials may be…
What Is the AGILE Study? Research for AML Patients With the IDH1 Mutation
https://vimeo.com/841012970 AML expert Dr. Omer Jamy reviews the results of the AGILE study, a clinical trial evaluating the efficacy and safety of ivosidenib + azacitidine vs placebo + azacitidine in…
When Should AML Patients Consider Joining a Clinical Trial?
https://vimeo.com/841012814 With AML research advancing quickly, clinical trials are an important consideration when making a treatment decision. AML expert and researcher Dr. Omer Jamy discusses when joining a clinical trial…
Expert Perspective | Key Advice for AML Patients
https://vimeo.com/841012867 Facing an AML diagnosis can feel overwhelming. Dr. Omer Jamy shares tips for newly diagnosed AML patients, emphasizing the importance of a consultation with a specialist. Dr. Omer Jamy…
Path to Empowerment: Multiple Myeloma | Clinical Trials
https://vimeo.com/840567202 Have you ever wanted to a hear a first-hand account from someone who has participated in a clinical trial? Hear from two patients as they describe their experience with…
How Can CAR T-Cell Therapy Care Partners Find Support?
https://vimeo.com/837712895 Where can CAR T-cell therapy care partners access support? Expert Sarah Meissner and Adrienne, a care partner, discuss resources and share self-care advice for those caring for a loved…